Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] is a coagulation Factor VIII concentrate indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.
Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei]
Search for Letters
Find documents for this product by entering your search terms in the box below.
Have a Question?
Request information directly from the Novo Nordisk
Medical Information department.
Have a Question?
All fields required.